- Recommendation ID
- NG14/05
- Question
Surveillance strategies: How frequently should surveillance imaging be conducted, and which imaging modality should be used for people with stage IIB to IIIC melanoma?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale and section on follow-up after treatment for melanoma.
Full details of the evidence and the committee's discussion are in evidence review G: follow-up of people with melanoma.
Source guidance details
- Comes from guidance
- Melanoma: assessment and management
- Number
- NG14
- Date issued
- July 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/07/2022 |